Your session is about to expire
← Back to Search
Verbalization Techniques for Lower Back Pain
N/A
Waitlist Available
Led By Joseph B Brence, DPT
Research Sponsored by Keystone Rehabilitation Systems
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Must not have
Pain whose origin could better be defined as peripheral neuropathic (history of nerve injury, pathology or mechanical compromise; pain in a dermatomal or cutaneous distribution; pain/symptoms provocation with movement tests that move or compress neural tissue (ex. SLR)
Any red-flags indicating the low back pain is caused by non-musculoskeletal pathology
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 1,4,12, 26
Awards & highlights
No Placebo-Only Group
Summary
This trial will test whether or not limiting complaints can help with pain and PC in individuals with LBP who are in a state of CS.
Who is the study for?
This trial is for adults over 18 with non-specific low back pain that seems out of proportion to any injury, feels unpredictable or widespread, and might be linked to psychological stress. It's not for those whose pain is sharp with movement, clearly tied to a specific area or injury, involves nerve issues, disturbs sleep significantly, or could be due to something other than musculoskeletal problems.
What is being tested?
The study tests if restricting how much patients with low back pain and central sensitization complain about their pain can affect the intensity of their discomfort and their tendency to catastrophize (exaggerate) the seriousness of their pain.
What are the potential side effects?
Since this intervention involves behavioral changes rather than medication or surgery, traditional side effects are not expected. However, participants may experience emotional or psychological responses from altering how they express pain.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
My pain is due to nerve damage and gets worse with certain movements.
Select...
My low back pain is not caused by bone or muscle issues.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ weeks 1,4,12,26
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weeks 1,4,12,26
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Visual Analogue Scale for Pain
Secondary study objectives
Pain Catastrophizing Scale
Other study objectives
Global Rating of Perceived Change
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Pain Verbalization Repression RulesExperimental Treatment1 Intervention
This group will wear a bracelet with a set of rules which will restrict ones verbalization of pain complaints
Find a Location
Who is running the clinical trial?
Keystone Rehabilitation SystemsLead Sponsor
1 Previous Clinical Trials
100 Total Patients Enrolled
Joseph B Brence, DPTPrincipal InvestigatorPhysiotherapy Associates
1 Previous Clinical Trials
100 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My pain is severe, doesn't match my injury, is unpredictable, or is linked to stress.My pain is due to nerve damage and gets worse with certain movements.I am over 18 and have been diagnosed with non-specific low back pain.My low back pain is not caused by bone or muscle issues.My pain is sharp with movement and worsens with certain positions.
Research Study Groups:
This trial has the following groups:- Group 1: Pain Verbalization Repression Rules
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger